Sorafenib/2800Z Co-Loaded into Cholesterol and PEG Grafted Polylysine NPs for Liver Cancer Treatment

• Main Authors: Chen Zhang (Author), Wu Zhong (Author), Ying Cao (Author), Bohao Liu (Author), Xiaojun Tao (Author), Zhuan Li (Author)
• Formato: Livro
• Publicado em: MDPI AG, 2023-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

The treatment of liver cancer remains challenging due to the low responsiveness of advanced cancer to therapeutic options. Sorafenib is the first line chemotherapeutic drug for advanced liver cancer but is frequently associated with severe side effects lead to discontinuation of chemotherapy. We pre...